Page last updated: 2024-08-23

mefloquine and Uterine Cervical Neoplasms

mefloquine has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banu, H; Hamal, S; Jiao, S; Li, H; Li, X; Wang, X	1

Other Studies

1 other study(ies) available for mefloquine and Uterine Cervical Neoplasms

Article	Year
Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1 Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Mefloquine; Membrane Potential, Mitochondrial; Mice, SCID; Mitochondria; Neoplastic Stem Cells; Paclitaxel; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms	2017

Article

Year

Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.

Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1

Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Mefloquine; Membrane Potential, Mitochondrial; Mice, SCID; Mitochondria; Neoplastic Stem Cells; Paclitaxel; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms

2017